Publication: Inflammatory features in sporadic late-onset nemaline myopathy are independent from monoclonal gammopathy
Issued Date
2021-05-01
Resource Type
ISSN
17503639
10156305
10156305
Other identifier(s)
2-s2.0-85106964793
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Bibliographic Citation
Brain Pathology. Vol.31, No.3 (2021)
Suggested Citation
Jantima Tanboon, Akinori Uruha, Yukie Arahata, Carsten Dittmayer, Leonille Schweizer, Hans Hilmar Goebel, Ichizo Nishino, Werner Stenzel Inflammatory features in sporadic late-onset nemaline myopathy are independent from monoclonal gammopathy. Brain Pathology. Vol.31, No.3 (2021). doi:10.1111/bpa.12962 Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/78221
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Inflammatory features in sporadic late-onset nemaline myopathy are independent from monoclonal gammopathy
Abstract
Sporadic late-onset nemaline myopathy (SLONM) is a rare adult-onset non-hereditary disease with subacute proximal muscle and often axial muscle weakness, characterized by the presence of nemaline bodies in skeletal muscle biopsies. Considering its association with concurrent monoclonal gammopathy of undetermined significance (MGUS), the disease is classified into two major subtypes (1) SLONM without MGUS (SLONM-noMGUS) and (2) with MGUS (SLONM-MGUS) association. SLONM associated with HIV infection (SLONM-HIV) is also reported. SLONM-MGUS has been shown to be associated with poorer prognosis and required aggressive treatment including high-dose melphalan and autologous stem cell transplantation. The approach is currently debatable as recent reports suggested effectiveness of intravenous immunoglobulin as initial treatment with indifference of overall survival despite the presence of MGUS. Our study aimed to find an underlying basis by review of pathological features in 49 muscle biopsy proven-SLONM from two large tertiary centers in Japan and Germany (n = 49: SLONM-noMGUS = 34, SLONM-MGUS = 13, SLONM-HIV = 2). We compared pathological findings in SLONM-noMGUS and SLONM-MGUS and focused on the presence of any detectable inflammatory features by immunohistochemistry. The clinical and histological features in SLONM-noMGUS and SLONM-MGUS were not distinctively different except for more common regenerating fibers (>5% of myofibers) present in SLONM-MGUS (p < 0.01). HLA-ABC expression and fine granular p62 were observed in 66.7% and 78.3% of SLONM, respectively. The predominant inflammatory cells were CD68+ cells. The inflammatory cells showed positive correlations with the percentage of nemaline-containing fibers (p < 0.001). In conclusion, inflammatory features are present although rather mild in SLONM. This finding contributes to the hypothesis of an acquired inflammatory disease pathogenesis and opens the possibility to offer immunotherapy in SLONM with inflammatory features regardless of the monoclonal gammopathy status.